Imunon (IMNN) said Friday it received positive data showing improvement in overall and progression-free survival from a phase 2 study of IMNN-001, an investigational therapy for the treatment of advanced ovarian cancer.
Shares more than doubled as intraday trading volume catapulted to over 330.6 million from a daily average of about 532,000.
Merus (MRUS) shares soared 36% amid heavy trading after the company reported favorable interim cancer trial results overnight.
Over 5.63 million shares traded intraday versus a daily average of roughly 836,000.
Douglas Elliman (DOUG) has received a merger offer from Anywhere Real Estate (HOUS) this week that would value the company at roughly double its current share price, Bloomberg reported Friday, citing people with knowledge of the matter.
Shares soared 33%, with intraday trading volume at nearly 12 million compared with a daily average of roughly 543,000.
Price: 1.10, Change: +0.68, Percent Change: +164.74
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。